Skip to main content

Table 2 Levels of soluble receptor for advanced glycation end products (sRAGE) in sera and in synovial fluid of rheumatoid arthritis patients according to different disease characteristics

From: Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

Disease characteristic n Blood sRAGE Synovial sRAGE
Erosive rheumatoid arthritis 39   
   Rheumatoid factor-positive 33 832 ± 87 (771) 345 ± 39 (323)
   Rheumatoid factor-negative 6 1105 ± 209 (935) 447 ± 171 (273)
Non-erosive rheumatoid arthritis 23   
   Rheumatoid factor-positive 5 582 ± 141 (602) 463 ± 153 (498)
   Rheumatoid factor-negative 18 945 ± 128 (772) 397 ± 79 (281)
  1. Data presented as the mean ± standard error of the mean (median).